268 related articles for article (PubMed ID: 15203981)
1. Detection of isolated tumor cells in peripheral blood and in BM: evaluation of a new enrichment method.
Naume B; Borgen E; Tøssvik S; Pavlak N; Oates D; Nesland JM
Cytotherapy; 2004; 6(3):244-52. PubMed ID: 15203981
[TBL] [Abstract][Full Text] [Related]
2. Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood.
Naume B; Borgen E; Beiske K; Herstad TK; Ravnås G; Renolen A; Trachsel S; Thrane-Steen K; Funderud S; Kvalheim G
J Hematother; 1997 Apr; 6(2):103-14. PubMed ID: 9131439
[TBL] [Abstract][Full Text] [Related]
3. Detection and analysis of cancer cells in blood and bone marrow using a rare event imaging system.
Kraeft SK; Sutherland R; Gravelin L; Hu GH; Ferland LH; Richardson P; Elias A; Chen LB
Clin Cancer Res; 2000 Feb; 6(2):434-42. PubMed ID: 10690521
[TBL] [Abstract][Full Text] [Related]
4. Immunocytochemical detection of tumor cells in bone marrow and peripheral blood stem cell collections from patients with ovarian cancer.
Ross AA; Miller GW; Moss TJ; Kahn DG; Warner NE; Sweet DL; Louie KG; Schneidermann E; Pecora AL; Meagher RC
Bone Marrow Transplant; 1995 Jun; 15(6):929-33. PubMed ID: 7581093
[TBL] [Abstract][Full Text] [Related]
5. Immunomagnetic detection and clinical significance of micrometastatic tumor cells in malignant melanoma patients.
Faye RS; Aamdal S; Høifødt HK; Jacobsen E; Holstad L; Skovlund E; Fodstad Ø
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4134-9. PubMed ID: 15217950
[TBL] [Abstract][Full Text] [Related]
6. Immunomagnetic separation for enrichment and sensitive detection of disseminated tumour cells in patients with head and neck SCC.
Partridge M; Phillips E; Francis R; Li SR
J Pathol; 1999 Nov; 189(3):368-77. PubMed ID: 10547599
[TBL] [Abstract][Full Text] [Related]
7. Immunomagnetic detection of micrometastatic cells in bone marrow of colorectal cancer patients.
Flatmark K; Bjørnland K; Johannessen HO; Hegstad E; Rosales R; Hårklau L; Solhaug JH; Faye RS; Søreide O; Fodstad Ø;
Clin Cancer Res; 2002 Feb; 8(2):444-9. PubMed ID: 11839662
[TBL] [Abstract][Full Text] [Related]
8. Influence of platinum-based chemotherapy on disseminated tumor cells in blood and bone marrow of patients with ovarian cancer.
Wimberger P; Heubner M; Otterbach F; Fehm T; Kimmig R; Kasimir-Bauer S
Gynecol Oncol; 2007 Nov; 107(2):331-8. PubMed ID: 17764727
[TBL] [Abstract][Full Text] [Related]
9. An immunomagnetic epithelial tumor cell enrichment model for minimal residual disease detection of cytokeratin 8+ malignancies.
Brooimans RA; de Leeuw N; Bontenbal M; Gratama JW
J Biol Regul Homeost Agents; 2005; 19(1-2):84-91. PubMed ID: 16178280
[TBL] [Abstract][Full Text] [Related]
10. Measuring circulating neuroblastoma cells by quantitative reverse transcriptase-polymerase chain reaction analysis.
Cheung IY; Sahota A; Cheung NK
Cancer; 2004 Nov; 101(10):2303-8. PubMed ID: 15484213
[TBL] [Abstract][Full Text] [Related]
11. Detection of isolated tumor cells in BM from breast-cancer patients: significance of anterior and posterior iliac crest aspirations and the number of mononuclear cells analyzed.
Wiedswang G; Borgen E; Karesen R; Naume B
Cytotherapy; 2003; 5(1):40-5. PubMed ID: 12745581
[TBL] [Abstract][Full Text] [Related]
12. Application of immunomagnetic cell enrichment in combination with RT-PCR for the detection of rare circulating head and neck tumor cells in human peripheral blood.
Tong X; Yang L; Lang JC; Zborowski M; Chalmers JJ
Cytometry B Clin Cytom; 2007 Sep; 72(5):310-23. PubMed ID: 17205568
[TBL] [Abstract][Full Text] [Related]
13. Comparison of two density gradient centrifugation systems for the enrichment of disseminated tumor cells in blood.
Rosenberg R; Gertler R; Friederichs J; Fuehrer K; Dahm M; Phelps R; Thorban S; Nekarda H; Siewert JR
Cytometry; 2002 Dec; 49(4):150-8. PubMed ID: 12454978
[TBL] [Abstract][Full Text] [Related]
14. Bi-specific immunomagnetic enrichment of micrometastatic tumour cell clusters from bone marrow of cancer patients.
Woelfle U; Breit E; Zafrakas K; Otte M; Schubert F; Müller V; Izbicki JR; Löning T; Pantel K
J Immunol Methods; 2005 May; 300(1-2):136-45. PubMed ID: 15907331
[TBL] [Abstract][Full Text] [Related]
15. Isolation and enrichment of urologic tumor cells in blood samples by a semi-automated CD45 depletion autoMACS protocol.
Meye A; Bilkenroth U; Schmidt U; Füssel S; Robel K; Melchior AM; Blümke K; Pinkert D; Bartel F; Linne C; Taubert H; Wirth MP
Int J Oncol; 2002 Sep; 21(3):521-30. PubMed ID: 12168095
[TBL] [Abstract][Full Text] [Related]
16. Detection of residual neuroblastoma cells in bone marrow: comparison of flow cytometry with immunocytochemistry.
Swerts K; De Moerloose B; Dhooge C; Brichard B; Benoit Y; Laureys G; Philippé J
Cytometry B Clin Cytom; 2004 Sep; 61(1):9-19. PubMed ID: 15351977
[TBL] [Abstract][Full Text] [Related]
17. Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen.
Schindlbeck C; Stellwagen J; Jeschke U; Karsten U; Rack B; Janni W; Jückstock J; Tulusan A; Sommer H; Friese K
Clin Exp Metastasis; 2008; 25(3):233-40. PubMed ID: 18185913
[TBL] [Abstract][Full Text] [Related]
18. Immunomagnetic cell enrichment detects more disseminated cancer cells than immunocytochemistry in vitro.
Zigeuner RE; Riesenberg R; Pohla H; Hofstetter A; Oberneder R
J Urol; 2000 Nov; 164(5):1834-7. PubMed ID: 11025779
[TBL] [Abstract][Full Text] [Related]
19. Flow cytometric phenotype of rhabdomyosarcoma bone marrow metastatic cells and its implication in differential diagnosis with neuroblastoma.
Bozzi F; Collini P; Aiello A; Barzanò E; Gambirasio F; Podda M; Meazza C; Ferrari A; Luksch R
Anticancer Res; 2008; 28(3A):1565-9. PubMed ID: 18630512
[TBL] [Abstract][Full Text] [Related]
20. [Detection and clinical significance of circulating tumor cells in peripheral blood of breast cancer patients].
Cai QQ; Huang HQ; Lin TX; Jiang WQ
Ai Zheng; 2005 Jul; 24(7):837-41. PubMed ID: 16004811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]